Literature DB >> 14656219

Glycoproteins VI and Ib-IX-V stimulate tyrosine phosphorylation of tyrosine kinase Syk and phospholipase Cgamma2 at distinct sites.

Katsue Suzuki-Inoue1, Jonathan I Wilde, Robert K Andrews, Jocelyn M Auger, Reuben P Siraganian, Fujio Sekiya, Sue Goo Rhee, Steve P Watson.   

Abstract

Glycoproteins GPVI and GPIb-IX-V stimulate robust tyrosine phosphorylation of Syk and PLCg2 (phospholipase Cg2) in washed platelets, but only the former stimulates pronounced activation of phospholipase. Using phospho-specific antibodies, we demonstrate that GPVI, but not GPIb-IX-V, stimulates significant tyrosine phosphorylation of Syk at the autophosphorylation site pY525/526, a marker of Syk activity. In addition, GPVI stimulates tyrosine phosphorylation of PLCg2 at Tyr753 and Tyr759, whereas GPIb-IX-V only induces significant phosphorylation at Tyr753. Both receptors stimulate tyrosine phosphorylation of Btk at the regulatory Tyr223 and Tyr551. Syk and Btk phosphorylate peptides from PLCg2 containing Tyr753 and Tyr759 respectively, suggesting that they may stimulate phosphorylation at these sites in phospholipase. Studies using PLCg2-deficient platelets demonstrated that phospholipase is not required for the activation of integrin aIIbb3 by GPIb-IX-V. Our results demonstrate fundamental differences between GPVI and GPIb-IX-V in the regulation of tyrosine phosphorylation of Syk and PLCg2 consistent with the functional impairment of phospholipase in signalling by GPIb-IX-V.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14656219      PMCID: PMC1224016          DOI: 10.1042/BJ20031430

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  29 in total

1.  Phospholipase Cgamma2 is essential in the functions of B cell and several Fc receptors.

Authors:  D Wang; J Feng; R Wen; J C Marine; M Y Sangster; E Parganas; A Hoffmeyer; C W Jackson; J L Cleveland; P J Murray; J N Ihle
Journal:  Immunity       Date:  2000-07       Impact factor: 31.745

2.  Interaction of linker for activation of T cells with multiple adapter proteins in platelets activated by the glycoprotein VI-selective ligand, convulxin.

Authors:  N Asazuma; J I Wilde; O Berlanga; M Leduc; A Leo; E Schweighoffer; V Tybulewicz; C Bon; S K Liu; C J McGlade; B Schraven; S P Watson
Journal:  J Biol Chem       Date:  2000-10-27       Impact factor: 5.157

3.  Association of Fyn and Lyn with the proline-rich domain of glycoprotein VI regulates intracellular signaling.

Authors:  Katsue Suzuki-Inoue; David Tulasne; Yang Shen; Teresa Bori-Sanz; Osamu Inoue; Stephanie M Jung; Masaaki Moroi; Robert K Andrews; Michael C Berndt; Steve P Watson
Journal:  J Biol Chem       Date:  2002-04-09       Impact factor: 5.157

4.  Integrin alpha IIb beta 3-dependent calcium signals regulate platelet-fibrinogen interactions under flow. Involvement of phospholipase C gamma 2.

Authors:  Isaac Goncalves; Sascha C Hughan; Simone M Schoenwaelder; Cindy L Yap; Yuping Yuan; Shaun P Jackson
Journal:  J Biol Chem       Date:  2003-06-27       Impact factor: 5.157

5.  Murine GPVI stimulates weak integrin activation in PLCgamma2-/- platelets: involvement of PLCgamma1 and PI3-kinase.

Authors:  Katsue Suzuki-Inoue; Osamu Inoue; Jon Frampton; Steve P Watson
Journal:  Blood       Date:  2003-05-01       Impact factor: 22.113

6.  Signaling role for phospholipase C gamma 2 in platelet glycoprotein Ib alpha calcium flux and cytoskeletal reorganization. Involvement of a pathway distinct from FcR gamma chain and Fc gamma RIIA.

Authors:  Pierre Mangin; Yuping Yuan; Isaac Goncalves; Anita Eckly; Monique Freund; Jean-Pierre Cazenave; Christian Gachet; Shaun P Jackson; François Lanza
Journal:  J Biol Chem       Date:  2003-06-17       Impact factor: 5.157

7.  Differential effects of reduced glycoprotein VI levels on activation of murine platelets by glycoprotein VI ligands.

Authors:  Daniel C Snell; Valerie Schulte; Gavin E Jarvis; Kanako Arase; Daiju Sakurai; Takashi Saito; Steve P Watson; Bernhard Nieswandt
Journal:  Biochem J       Date:  2002-11-15       Impact factor: 3.857

8.  Interaction between von Willebrand factor and glycoprotein Ib activates Src kinase in human platelets: role of phosphoinositide 3-kinase.

Authors:  Yi Wu; Naoki Asazuma; Kaneo Satoh; Yutaka Yatomi; Toshiro Takafuta; Michael C Berndt; Yukio Ozaki
Journal:  Blood       Date:  2002-08-29       Impact factor: 22.113

9.  Integrin alpha2beta1 mediates outside-in regulation of platelet spreading on collagen through activation of Src kinases and PLCgamma2.

Authors:  Osamu Inoue; Katsue Suzuki-Inoue; William L Dean; Jon Frampton; Steve P Watson
Journal:  J Cell Biol       Date:  2003-03-03       Impact factor: 10.539

10.  Localization of the adhesion receptor glycoprotein Ib-IX-V complex to lipid rafts is required for platelet adhesion and activation.

Authors:  Corie N Shrimpton; Gautam Borthakur; Susana Larrucea; Miguel A Cruz; Jing-Fei Dong; José A López
Journal:  J Exp Med       Date:  2002-10-21       Impact factor: 14.307

View more
  20 in total

1.  Impaired Glycoprotein VI-Mediated Signaling and Platelet Functional Responses in CD45 Knockout Mice.

Authors:  Vaishali V Inamdar; John C Kostyak; Rachit Badolia; Carol A Dangelmaier; Bhanu Kanth Manne; Akruti Patel; Soochong Kim; Satya P Kunapuli
Journal:  Thromb Haemost       Date:  2019-06-21       Impact factor: 5.249

2.  Distinct pathways regulate Syk protein activation downstream of immune tyrosine activation motif (ITAM) and hemITAM receptors in platelets.

Authors:  Bhanu Kanth Manne; Rachit Badolia; Carol Dangelmaier; Johannes A Eble; Wilfried Ellmeier; Mark Kahn; Satya P Kunapuli
Journal:  J Biol Chem       Date:  2015-03-12       Impact factor: 5.157

3.  Phosphoproteomic quantitation and causal analysis reveal pathways in GPVI/ITAM-mediated platelet activation programs.

Authors:  Özgün Babur; Alexander R Melrose; Jennifer M Cunliffe; John Klimek; Jiaqing Pang; Anna-Liisa I Sepp; Jevgenia Zilberman-Rudenko; Samuel Tassi Yunga; Tony Zheng; Iván Parra-Izquierdo; Jessica Minnier; Owen J T McCarty; Emek Demir; Ashok P Reddy; Phillip A Wilmarth; Larry L David; Joseph E Aslan
Journal:  Blood       Date:  2020-11-12       Impact factor: 22.113

Review 4.  Platelet immunoreceptor tyrosine-based activation motif (ITAM) signaling and vascular integrity.

Authors:  Yacine Boulaftali; Paul R Hess; Mark L Kahn; Wolfgang Bergmeier
Journal:  Circ Res       Date:  2014-03-28       Impact factor: 17.367

5.  Peroxiredoxin II is an antioxidant enzyme that negatively regulates collagen-stimulated platelet function.

Authors:  Ji Yong Jang; Su Bin Wang; Ji Hyun Min; Yun Hee Chae; Jin Young Baek; Dae-Yeul Yu; Tong-Shin Chang
Journal:  J Biol Chem       Date:  2015-03-23       Impact factor: 5.157

6.  C-type lectin like receptor 2 (CLEC-2) signals independently of lipid raft microdomains in platelets.

Authors:  Bhanu Kanth Manne; Rachit Badolia; Carol A Dangelmaier; Satya P Kunapuli
Journal:  Biochem Pharmacol       Date:  2014-11-20       Impact factor: 5.858

7.  Rapid ubiquitination of Syk following GPVI activation in platelets.

Authors:  Carol A Dangelmaier; Patricia G Quinter; Jianguo Jin; Alexander Y Tsygankov; Satya P Kunapuli; James L Daniel
Journal:  Blood       Date:  2005-02-08       Impact factor: 22.113

8.  Reactive oxygen species play a critical role in collagen-induced platelet activation via SHP-2 oxidation.

Authors:  Ji Yong Jang; Ji Hyun Min; Yun Hee Chae; Jin Young Baek; Su Bin Wang; Su Jin Park; Goo Taeg Oh; Sang-Hak Lee; Ye-Shih Ho; Tong-Shin Chang
Journal:  Antioxid Redox Signal       Date:  2014-01-30       Impact factor: 8.401

9.  Fucoidan is a novel platelet agonist for the C-type lectin-like receptor 2 (CLEC-2).

Authors:  Bhanu Kanth Manne; Todd M Getz; Craig E Hughes; Osama Alshehri; Carol Dangelmaier; Ulhas P Naik; Steve P Watson; Satya P Kunapuli
Journal:  J Biol Chem       Date:  2013-01-22       Impact factor: 5.157

10.  von Willebrand factor mutation promotes thrombocytopathy by inhibiting integrin αIIbβ3.

Authors:  Caterina Casari; Eliane Berrou; Marilyne Lebret; Frédéric Adam; Alexandre Kauskot; Régis Bobe; Céline Desconclois; Edith Fressinaud; Olivier D Christophe; Peter J Lenting; Jean-Philippe Rosa; Cécile V Denis; Marijke Bryckaert
Journal:  J Clin Invest       Date:  2013-11-25       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.